Viewing nowCombinationAvatree Tablet 5/80/10 milligrams
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202006660 · Approved 2020.09.25 · Insurance code 669908020
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease (including myocardial infarction)
This medication is used for patients who need to take Amlodipine/Valasartan combination and Atorvastatin simultaneously. The Amlodipine/Valasartan combination helps effectively lower blood pressure in patients with essential hypertension who find it difficult to control blood pressure with monotherapy. Atorvastatin reduces the risk of cardiovascular disease and decreases cholesterol and triglyceride levels in patients with dyslipidemia, thereby improving vascular health. It is particularly useful for patients at high risk for coronary artery disease, patients with diabetes, and those with dyslipidemia. This medication is used to manage blood pressure control, reduce cardiovascular disease risk, and manage dyslipidemia together.
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking the amlodipine/valsartan combination together with atorvastatin as separate tablets may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Before and during treatment with atorvastatin, patients should follow a standard cholesterol-lowering diet. Atorvastatin may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; it should be discontinued immediately if pregnancy is confirmed. If muscle-related symptoms or a significant increase in muscle enzyme levels occur while taking this medication, it should be stopped immediately. Patients with certain conditions, severely impaired liver or kidney function, hypersensitivity, and women who are pregnant or breastfeeding should not use this medication. Patients with sodium or fluid depletion, hyperkalemia, and those with vascular problems in the kidneys require caution while using this medication, and close monitoring by healthcare providers before and after administration is necessary. Dizziness or fatigue may occur while taking this medication, so care should be taken when driving or operating machinery. Since this medication may interact with other drugs, particularly those metabolized by the liver or certain antibiotics, antifungals, and immunosuppressants, inform healthcare providers and adjustment or monitoring of doses may be required. This medication can affect liver and kidney function, so regular blood tests and liver function tests are recommended. If symptoms such as myalgia, muscle weakness, fever, or malaise occur, inform healthcare providers immediately, and if severe, discontinue the medication. This medication is not recommended for women who are pregnant or breastfeeding, and women of childbearing age should use appropriate contraceptive methods. Regular consultation with healthcare providers is advised during medication use, and any unusual symptoms or suspected side effects should be reported immediately.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer period.
White oval film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.